個股熱度排行 | 11月18日港股盤前
根據uSMART輿情監測數據,從17日晚間到18日港股盤前時間段,市場關注指數最高的5只股票是阿裏巴巴-SW、網易-S、騰訊控股、百濟神州、凱萊英。
11月18日—港股關注排行TOP5

阿裏巴巴-SW

關注度第一爲阿裏巴巴-SW,該股上個交易日收盤下跌0.70%,報於78.25港元。近5個交易日累計上漲24.21%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:
阿裏:股份回購計劃增加150億美元 有效期延長至2025財年底
阿裏巴巴:第三季度歸屬股東淨虧損人民幣205.61億元 同比由盈轉虧
網易-S

關注度第二爲網易-S,該股上個交易日收盤下跌9.05%,報於103.50港元。近5個交易日累計上漲12.68%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:
網易-S:首9月歸屬股東淨利潤163.85億人民幣 每股派息0.087美元
網易將斥資不超過50億美元回購股票
騰訊控股

關注度第三爲騰訊控股,該股上個交易日收盤下跌0.82%,報於292.00港元。近5個交易日累計上漲26.19%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:
2022年11月共70款遊戲獲批 騰訊、網易旗下遊戲在列
深圳市騰訊計算機今年首獲遊戲版號
百濟神州

關注度第四爲百濟神州,該股上個交易日收盤下跌1.42%,報於125.30港元。近5個交易日累計上漲13.39%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:
百濟神州:歐盟委員會批準百悅澤®用於治療慢性淋巴細胞白血病成人患者
百濟神州百悅澤?獲歐盟委員會批準,用於治療慢性淋巴細胞白血病成人患者
凱萊英

關注度第五爲凱萊英,該股上個交易日收盤下跌0.38%,報於105.80港元。近5個交易日累計上漲14.01%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:
凱萊英擬推2022年員工持股計劃
凱萊英制定A股員工持股計劃 規模不超1.56億元人民幣
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.